Next Article in Journal
Role of Receptor Profiling for Personalized Therapy in a Patient with a Growth Hormone-Secreting Macroadenoma Resistant to First-Generation Somatostatin Analogues
Next Article in Special Issue
Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program
Previous Article in Journal
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Previous Article in Special Issue
Access to Genetic Counselors in the Southern United States
 
 
Article

Article Versions Notes

J. Pers. Med. 2019, 9(4), 47; https://doi.org/10.3390/jpm9040047
Action Date Notes Link
article xml file uploaded 1 November 2019 10:20 CET Original file -
article xml uploaded. 1 November 2019 10:20 CET Update https://www.mdpi.com/2075-4426/9/4/47/xml
article pdf uploaded. 1 November 2019 10:20 CET Version of Record https://www.mdpi.com/2075-4426/9/4/47/pdf
article html file updated 1 November 2019 10:21 CET Original file -
article html file updated 31 December 2019 20:06 CET Update -
article html file updated 14 February 2020 05:52 CET Update -
article html file updated 20 July 2022 00:29 CEST Update https://www.mdpi.com/2075-4426/9/4/47/html
Back to TopTop